fbpx
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • Read the study description.
  • Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability and share the Participant Informed Consent Form for you to read.

Study Information

New Zealand Clinical Research is trialling an investigational drug that may potentially be used for the treatment of obesity and/or insulin resistance (e.g., type 2 diabetes).

Worldwide, obesity and diabetes affect approximately 12-13% of adults. This rate continues to grow every year. The two conditions are closely linked and can lead to other serious consequences, including heart disease.

The drug targets the liver to enhance breakdown of fat and overall reduce the fat content in the liver. This action improves the sensitivity of the body to insulin, lower blood sugars, and decrease risk of developing diabetes or the severity of diabetes.

It is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

This study (2023 FULL 15237) is being funded by OrsoBio, Inc. and has been approved by the Health and Disability Ethics Committee.

Requirements

Healthy Males and Females

  • 1 (or more) unsuccessful weight loss attempt(s)
  • No change in weight of more than 5 kg within prior 90 days
  • Not currently taking any weight loss medications
  • Aged between 18 – 70 years
  • BMI (Body Mass Index) between 30 – 50 kg/m²
  • Non-smokers or ex-smokers

What is Involved?

  • Study Visits: 9 clinic visits + 2 optional MRI appointments
  • Reimbursement: Up to $4,300 before tax + optional $300 before tax

Important Documents

Important documents to download and read

Pre-screening Form

Azure Part G

Pre screening for Azure Part G

Personal details

Please provide your name, email and phone number so we can contact you
NZCR Site(Required)
Which site are you located at?

Medical questions

Have you had any covid symptoms in the last 4 weeks or been in isolation?
Have you previously participated in a study with NZCR or any other organisation?
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Have you received blood or plasma in the last 56 days? If yes please provide details
The study does not accept any current smokers. Have you used any nicotine or tobacco containing products in the last 3 months?
Have you received any vaccinations in the last 14 days?
Do you have any History of Diabetes?
Have you had any history of skin diseases such as rash, food allergies, psoriasis or hives?
Any history of abnormal liver or kidney conditions?
Do you have any significant heart disease or heart related conditions/abnormalities? Do you have any family history of heart conditions?
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Any significant history of acid reflux or peptic (stomach) ulcers?
Do you have any history of clinically significant acute systemic infection and/or antibiotic treatment within 28 days?
Have you been sick in the last 30 days?
Have you ever undergone any gastric or intestinal surgery? For example, gastric bypass and gastric sleeve.
Do you have any history of medical conditions relating to:(Required)
If you have none, please select the last option.
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 28 days? Please include any Vaccines in the last 3 months
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. This means having flexibility for more than one group increases your chances of being accepted into a group.
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.